Top compounds associated with response to LINC00675


Feature Type Standardized
Nominal ANOVA
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.098 0.01
mRNA L-685458 CCLE pan-cancer AAC 0.12 0.01
mRNA SID 26681509 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.01
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC -0.099 0.01
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.01
mRNA Bortezomib gCSI pan-cancer AAC -0.16 0.01
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.02
mRNA procarbazine CTRPv2 pan-cancer AAC 0.1 0.02
mRNA tamatinib CTRPv2 pan-cancer AAC -0.097 0.02
Download CSV